Purchase Order 75N91020P00622
Award Date 7/17/20
Potential Completion Date 8/15/20
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lawrence, MA 01843, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on September 14, 2020, for scientific equipment on a firm fixed price basis. Performance will occur in Lawrence, Massachusetts, with an ultimate completion date of November 11, 2020. No small business set-aside was applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on July 30, 2020, with an ultimate completion date of August 31, 2020. The order procures scientific equipment on a firm fixed price basis. Performance occurs at Nexcelom's facility in Lawrence, Massachusetts. No set-aside category was applied.</p>
- This is a $14,955.00 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency, to Nexcelom Bioscience LLC for a service contract to provide a cytometer. The contract has no set-aside designation and was awarded on June 28, 2020 with a completion date of June 27, 2021. Nexcelom Bioscience LLC is a for-profit limited liability company that develops and markets image cytometry products for cell analysis used in life science and biomedical research. Through prior...
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>
- <p>The National Cancer Institute awarded a purchase order to EMD Millipore Corp for $24,879.65 in laboratory equipment and supplies on September 15, 2020, with completion by December 1, 2020. Performance takes place in Burlington, Massachusetts. The order carries no small business set-aside. Pricing is firm fixed price.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Nexcelom Bioscience LLC for $36,540.00 on April 23, 2020. Performance takes place in Lawrence, Massachusetts. The order procures image cytometry equipment and related scientific instrumentation for cell analysis in biomedical research. Completion is scheduled for May 28, 2020. The underlying solicitation was posted April 6, 2020 with award authority exercised April 23, 2020.</p>
- <p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $97,997.20 on April 4, 2017, for maintenance services for a Delta Vision OMX instrument. The order is firm fixed price with no small business set-aside. Place of performance is Marlborough, Massachusetts. The ultimate completion date is April 3, 2022.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $22,130 in lab equipment on June 9, 2021, with completion by July 9, 2021. The award carries no small business set-aside. Performance is in Carlsbad, California. The order is firm fixed price and was issued to de-obligate expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 close of the period of availability.</p>
- <p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $7,821.75 on March 14, 2019, with an ultimate completion date of March 14, 2020. The order is firm fixed price with no set-aside designation. Place of performance is Gaithersburg, Maryland. The purchase order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH Office of Administrative Law and Management communication.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,950 purchase order to Intera Oncology Inc. for laboratory equipment. The firm fixed price contract has a period of performance from September 6, 2023 through October 28, 2023 and will be performed in Wellesley Hills, Massachusetts. No additional details were provided regarding the specific laboratory equipment being procured. The National Cancer Institute conducts and supports...
The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $24,732.00 on July 17, 2020, for scientific equipment. Performance occurs in Lawrence, Massachusetts. The order uses firm fixed price and carries no small business set-aside. Ultimate completion is August 15, 2020.
Generated 5/30/26, 10:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 7/16/20 |